Cancer Immunology and Immunotherapy Clinical Trials in CCR
Physician-scientists at the Center for Cancer Research are actively testing new immunotherapeutics in clinical trials aimed at improving outcomes for patients with cancer, HIV, or immunodeficiency disorders. Patients are seen at the NIH Clinical Center, the Nation’s largest hospital dedicated entirely to clinical research.
These are generally phase 1 or phase 2 trials, and have included several first-in-human clinical studies. Examples of some of our ongoing trials are identifying new antigen receptor targets for CAR T cells, as well as combining immunotherapy with more standard treatment approaches such as chemotherapy, radiotherapy or cytokines.
Current Open Trials
If you would like more details on a trial, contact the referral nurse listed.
- 1 of 5
- next ›